EBITDA: Income before interest, taxes, depreciation and amortization.
XORTX Therapeutics Inc. (XRTX) had EBITDA of $-3.14M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-2.66M |
|
-- |
|
-- |
|
$3.26M |
|
$-3.26M |
|
$0.60M |
|
$-2.66M |
|
$-2.65M |
|
$-2.66M |
|
$-2.66M |
|
$-2.66M |
|
$-2.65M |
|
$-3.26M |
|
|
EBITDA |
$-3.14M |
0.95M |
|
0.95M |
|
$-2.80 |
|
$-2.80 |
|
| Balance Sheet Financials | |
$1.26M |
|
$0.04M |
|
$1.42M |
|
$2.68M |
|
$0.60M |
|
-- |
|
-- |
|
$0.60M |
|
$2.08M |
|
$1.90M |
|
$2.08M |
|
1.39M |
|
| Cash Flow Statement Financials | |
$-2.77M |
|
$-0.29M |
|
$1.43M |
|
$2.47M |
|
$0.86M |
|
$-1.61M |
|
$0.03M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.11 |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.77M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-127.43% |
|
-139.87% |
|
-98.99% |
|
-127.43% |
|
$1.50 |
|
$-2.92 |
|
$-2.92 |
|